Immunostaining revealed that the combination of CMTR1 knockdown and anti-PD1 treatment resulted in significantly increased recruitment of CD8 + T cells into the tumor microenvironment compared with that resulting from anti-PD1 treatment or CMTR1 knockdown alone (Fig. 6F, G). This evidence concerns the gene CMTR1 and neoplasm.